HAMILTON, ON, Canada and GÖTTINGEN, Germany, January 21, 2025 / Biotech Newswire / --

加拿大安大略省汉密尔顿和德国哥廷根，2025年1月21日/生物技术通讯社/--

The life science group

生命科学小组

Sartorius

缝匠

and

和

McMaster University

麦克马斯特大学

today opened a new bioprocessing automation lab at the university’s Faculty of Engineering in Hamilton, Ontario. The state-of-the-art, 1,600-square-foot research facility was created complementing a substantial contribution of advanced biomanufacturing equipment from Sartorius, a long-standing partner of the university.

今天，在安大略省汉密尔顿的大学工程学院开设了一个新的生物加工自动化实验室。该实验室占地1600平方英尺，是最先进的研究设施，是对该大学长期合作伙伴Sartorius先进生物制造设备的重大贡献的补充。

The lab will serve as a training and development hub, where McMaster students and Sartorius employees work with other industry partners to accelerate developments in bioprocess modelling, simulation and advanced control..

该实验室将作为一个培训和发展中心，麦克马斯特的学生和Sartorius的员工将与其他行业合作伙伴合作，加速生物过程建模、仿真和先进控制的发展。。

“The opening of the Sartorius Bioprocess Automation Lab marks a milestone in McMaster’s commitment to advancing biomanufacturing capabilities in Canada,”

“萨托利斯生物过程自动化实验室的开放标志着麦克马斯特致力于提高加拿大生物制造能力的里程碑

says Dr. Heather Sheardown, Dean of the Faculty of Engineering at McMaster University.

麦克马斯特大学工程学院院长希瑟·希当博士说。

“This generous contribution will support technological innovations in large-scale biotherapeutics manufacturing that enhance production efficiency and ultimately expand access to life-saving treatments for chronic illnesses such as autoimmune disorders and cancers.”

“这一慷慨捐助将支持大规模生物治疗药物制造的技术创新，从而提高生产效率，并最终扩大对自身免疫性疾病和癌症等慢性疾病的救生治疗。”

Prof. Dr. Oscar-Werner Reif, Chief Technology Officer of Sartorius, adds,

Sartorius首席技术官Oscar Werner Reif教授补充道，

“This partnership enables McMaster University and Sartorius to explore and industrialize innovative bioprocessing solutions together with partners from the biopharmaceutical industry. In this state-of-the-art facility young researchers from academia and the industry will jointly develop innovative modelling and predictive control solutions that help to simplify and accelerate biomanufacturing processes – ultimately driving faster developments of improved therapies that will be accessible to patients around the world.”.

“这种合作关系使麦克马斯特大学和萨托利斯能够与生物制药行业的合作伙伴一起探索创新的生物加工解决方案并将其产业化。在这个最先进的设施中，来自学术界和业界的年轻研究人员将共同开发创新的建模和预测控制解决方案，帮助简化和加速生物制造过程，最终推动世界各地患者可以获得的改进疗法的更快发展。”。

The funding for the new facility comes via stage two of the Biosciences Research Infrastructure Fund (BRIF) competition, the centerpiece of a $2.2 billion CAD national program developed to build a strong and resilient domestic biomanufacturing and life sciences sector. This makes it the first BRIF-funded facility to open in Canada..

。这使其成为加拿大首家由BRIF资助的设施。。

“In the crucial biomanufacturing field, the opening of this lab will help Canadian researchers secure the competitive advantage they need to maintain the prosperity, health and security of our country,”

“在至关重要的生物制造领域，该实验室的开放将帮助加拿大研究人员获得维持国家繁荣、健康和安全所需的竞争优势。”

said Dr. Sylvain Charbonneau, President and CEO of the Canada Foundation for Innovation.

加拿大创新基金会主席兼首席执行官SylvainCharbonneau博士说。

“With public and private sector support, this cutting-edge facility will help prepare the new generation of innovators.”

“在公共和私营部门的支持下，这一尖端设施将有助于培养新一代创新者。”

Building on these contributions, a team of McMaster researchers has secured additional Alliance Grant funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) to launch an extensive four-year collaboration with Sartorius.

在这些贡献的基础上，麦克马斯特研究团队获得了加拿大自然科学与工程研究委员会（NSERC）的额外联盟资助，与Sartorius展开了为期四年的广泛合作。

Dr. David Latulippe, associate professor of chemical engineering and co-director of the Biointerfaces Institute at McMaster University, and the principal investigator on the Alliance Grant, says:

麦克马斯特大学（McMaster University）化学工程副教授、生物界面研究所（Biointerfaces Institute）联合主任、联盟赠款首席研究员David Latulippe博士表示：

“We are deeply grateful to Sartorius for their generosity and vision. Training our graduate and undergraduate students on the highly specialized equipment in the Bioprocessing Automation Lab is critical to the growth of Canada’s biomanufacturing economy, which is currently experiencing a severe talent shortage.”.

“我们非常感谢Sartorius的慷慨和远见。在生物加工自动化实验室对我们的研究生和本科生进行高度专业化的设备培训，对于加拿大生物制造经济的发展至关重要，目前加拿大正经历着严重的人才短缺。”。

The partnership started in 2019, when Sartorius joined the McMaster Advanced Control Consortium (MACC). In 2021, both partners teamed up to improve manufacturing processes of antibody and virus-based treatments for diseases such as COVID-19, cancers, and genetic disorders. Since then, the company has continuously provided valuable training opportunities for students at its research and development facilities in North America and Europe..

该合作始于2019年，当时Sartorius加入了麦克马斯特先进控制联盟（MACC）。2021年，双方合作改进了针对新型冠状病毒、癌症和遗传性疾病等疾病的抗体和基于病毒的治疗方法的制造工艺。从那时起，该公司一直在北美和欧洲的研发机构为学生提供宝贵的培训机会。。

For high resolution please click the image.

要获得高分辨率，请单击图像。

About

关于

Sartorius

缝匠

Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes.

Sartorius是生命科学研究和生物制药行业的领先国际合作伙伴。凭借创新的实验室仪器和耗材，该集团的实验室产品与服务部门专注于在制药和生物制药公司以及学术研究机构进行研究和质量控制的实验室。

The Bioprocess Solutions Division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. The company, based in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide.

生物过程解决方案部门以其广泛的产品组合为重点，专注于一次性使用解决方案，帮助客户安全、快速、经济地生产生物技术药物、疫苗以及细胞和基因疗法。。

Sartorius regularly expands its portfolio through the acquisition of complementary technologies. In 2023, the company generated sales revenue of around 3.4 billion euros. Currently, around 14,000 employees are working for customers around the globe..

Sartorius通过收购互补技术定期扩大其投资组合。2023年，该公司产生了约34亿欧元的销售收入。目前，全球约有14000名员工为客户工作。。

Visit our

访问我们的

Newsroom

新闻编辑室

or follow us on

或者继续关注我们

LinkedIn

LinkedIn

.

.

About

关于

McMaster

麦克马斯特

University

大学

McMaster is a research-intensive university ranked among the best in the world with a bold ambition to advance human and societal health and well-being. Among Canada’s top universities for student services, our research excellence is matched by our long history of teaching innovations and commitment to preparing students for an increasingly complex future.

麦克马斯特大学是一所研究密集型大学，位列世界顶尖大学之列，拥有促进人类和社会健康与福祉的大胆雄心。在加拿大顶尖的学生服务大学中，我们的卓越研究与我们悠久的教学创新历史相匹配，并致力于为学生迎接日益复杂的未来做好准备。

Our alumni continue to be among the most employable graduates globally, as they bring the McMaster vision of a brighter world to communities near and far..

我们的校友仍然是全球最具就业能力的毕业生之一，因为他们为远近的社区带来了麦克马斯特对更光明世界的愿景。。

Contacts

联系人

Sartorius

缝匠

Leona Malorny

利昂娜·马洛尼

Head of External Communications

外部沟通负责人

+49 551 308 4067

+49 551 308 4067

This email address is being protected from spambots. You need JavaScript enabled to view it.

此电子邮件地址受到垃圾邮件的保护。您需要启用JavaScript才能查看它。

McMaster University

麦克马斯特大学

Keiko Kataoka

当前页面

Communications Manager

通信经理

+1 416 805 1270

+1 416 805 1270

This email address is being protected from spambots. You need JavaScript enabled to view it.

此电子邮件地址受到垃圾邮件的保护。您需要启用JavaScript才能查看它。

Keywords: Manufacturing and Industrial Facilities; Laboratories; Biological Products; Cell Culture Techniques; Biotechnology; Life Science; Germany; Collaboration; Sartorius; Biomanufacturing lab; McMaster University; Canada; Bioprocessing automation lab; Training; Accelerated biomanufacturing; Bioprocess modelling; Simulation; Biotherapeutics manufacturing; Biopharmaceutical industry; Biosciences Research Infrastructure Fund (BRIF); Canadian biomanufacturing; Antibody manufacturing; Virus-based treatments; Single-use solutions; Biotech medications; Göttingen, Germany.

关键词：制造业和工业设施；实验室；生物制品；细胞培养技术；生物技术；生命科学；德国；协作；缝匠；生物制造实验室；；加拿大；生物处理自动化实验室；培训；加速生物制造；生物过程建模；模拟；生物治疗药物制造；生物制药工业；生物科学研究基础设施基金（BRIF）；加拿大生物制造；抗体制造；基于病毒的治疗；一次性使用解决方案；生物技术药物；德国哥廷根。

Source: Biotech Newswire

资料来源：Biotech Newswire